NFKB1 and lung carcinoma: Compounds targeting the NF-κB pathway are able to sensitize lung tumor cells by counteracting resistance mechanisms, and therefore, deserve further evaluation with regard to chemotherapy and the possible chemoprevention of lung cancer (25–27).